Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2018, Article ID 6473728, 12 pages
https://doi.org/10.1155/2018/6473728
Research Article

Metabolic Changes Associated with a Rat Model of Diabetic Depression Detected by Ex Vivo 1H Nuclear Magnetic Resonance Spectroscopy in the Prefrontal Cortex, Hippocampus, and Hypothalamus

1Radiology Department of the Second Affiliated Hospital and Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou 325035, China
2School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China

Correspondence should be addressed to Zhihan Yan; moc.liamtoh@naynahihz and Hongchang Gao; nc.ude.umw@72choag

Received 9 December 2017; Revised 12 February 2018; Accepted 11 March 2018; Published 8 April 2018

Academic Editor: Fang Pan

Copyright © 2018 Kun Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Rotella and E. Mannucci, “Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies,” The Journal of Clinical Psychiatry, vol. 74, no. 1, pp. 31–37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Roy and C. E. Lloyd, “Epidemiology of depression and diabetes: a systematic review,” Journal of Affective Disorders, vol. 142, pp. S8–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Semenkovich, M. E. Brown, D. M. Svrakic, and P. J. Lustman, “Depression in type 2 diabetes mellitus: prevalence, impact, and treatment,” Drugs, vol. 75, no. 6, pp. 577–587, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. R. D. Goldney, P. J. Phillips, L. J. Fisher, and D. H. Wilson, “Diabetes, depression, and quality of life: a population study,” Diabetes Care, vol. 27, no. 5, pp. 1066–1070, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. W. J. Katon, C. Rutter, G. Simon et al., “The association of comorbid depression with mortality in patients with type 2 diabetes,” Diabetes Care, vol. 28, no. 11, pp. 2668–2672, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Moussavi, S. Chatterji, E. Verdes, A. Tandon, V. Patel, and B. Ustun, “Depression, chronic diseases, and decrements in health: results from the World Health Surveys,” Lancet, vol. 370, no. 9590, pp. 851–858, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Wayhs, C. P. Mescka, C. S. Vanzin et al., “Brain effect of insulin and clonazepam in diabetic rats under depressive-like behavior,” Metabolic Brain Disease, vol. 28, no. 4, pp. 563–570, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Zanoveli, H. de Morais, I. C. da Silva Dias, A. K. Schreiber, C. P. de Souza, and J. M. da Cunha, “Depression associated with diabetes: from pathophysiology to treatment,” Current Diabetes Reviews, vol. 12, no. 3, pp. 165–178, 2016. View at Publisher · View at Google Scholar
  9. H. de Morais, C. P. de Souza, L. M. da Silva et al., “Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats,” Behavioural Brain Research, vol. 258, pp. 52–64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. D. P. Auer, B. Putz, E. Kraft, B. Lipinski, J. Schill, and F. Holsboer, “Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study,” Biological Psychiatry, vol. 47, no. 4, pp. 305–313, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Hasler, J. W. van der Veen, T. Tumonis, N. Meyers, J. Shen, and W. C. Drevets, “Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy,” Archives of General Psychiatry, vol. 64, no. 2, pp. 193–200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Ajilore, E. Haroon, S. Kumaran et al., “Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy,” Neuropsychopharmacology, vol. 32, no. 6, pp. 1224–1231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Xu, U. Dydak, J. Harezlak et al., “Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation,” Psychiatry Research, vol. 213, no. 3, pp. 235–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Glodzik-Sobanska, A. Slowik, P. McHugh et al., “Single voxel proton magnetic resonance spectroscopy in post-stroke depression,” Psychiatry Research, vol. 148, no. 2-3, pp. 111–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Hu, X. Cheng, X. Ye et al., “Ex vivo 1H nuclear magnetic resonance spectroscopy reveals systematic alterations in cerebral metabolites as the key pathogenetic mechanism of bilirubin encephalopathy,” Molecular Brain, vol. 7, no. 1, p. 87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. H. Wang, L. T. Yin, H. Yang, X. L. Li, and K. G. Wu, “Hypoglycemic and anti-depressant effects of Zuogui Jiangtang Jieyu formulation in a model of unpredictable chronic mild stress in rats with diabetes mellitus,” Experimental and Therapeutic Medicine, vol. 8, no. 1, pp. 281–285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Willner, “Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation,” Psychopharmacology, vol. 134, no. 4, pp. 319–329, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Zhou, M. Wang, X. Wang et al., “Abnormal expression of microRNAs induced by chronic unpredictable mild stress in rat hippocampal tissues,” Molecular Neurobiology, vol. 55, no. 2, pp. 917–935, 2018. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Morris, “Developments of a water-maze procedure for studying spatial learning in the rat,” Journal of Neuroscience Methods, vol. 11, no. 1, pp. 47–60, 1984. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Liu, X. J. Ye, W. Y. Hu et al., “Neurochemical changes in the rat occipital cortex and hippocampus after repetitive and profound hypoglycemia during the neonatal period: an ex vivo 1H magnetic resonance spectroscopy study,” Molecular Neurobiology, vol. 48, no. 3, pp. 729–736, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Coen, E. M. Lenz, J. K. Nicholson, I. D. Wilson, F. Pognan, and J. C. Lindon, “An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy,” Chemical Research in Toxicology, vol. 16, no. 3, pp. 295–303, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. A. Westerhuis, E. J. J. van Velzen, H. C. Hoefsloot, and A. K. Smilde, “Multivariate paired data analysis: multilevel PLSDA versus OPLSDA,” Metabolomics, vol. 6, no. 1, pp. 119–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zheng, Y. Yang, B. Dong et al., “Metabonomic profiles delineate potential role of glutamate-glutamine cycle in db/db mice with diabetes-associated cognitive decline,” Molecular Brain, vol. 9, no. 1, p. 40, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Hertz, R. Dringen, A. Schousboe, and S. R. Robinson, “Astrocytes: glutamate producers for neurons,” Journal of Neuroscience Research, vol. 57, no. 4, pp. 417–428, 1999. View at Publisher · View at Google Scholar
  25. C. Zhao and S. C. Gammie, “Glutamate, GABA, and glutamine are synchronously upregulated in the mouse lateral septum during the postpartum period,” Brain Research, vol. 1591, pp. 53–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. S. N. Goyal, N. M. Reddy, K. R. Patil et al., “Challenges and issues with streptozotocin-induced diabetes - a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics,” Chemico-Biological Interactions, vol. 244, pp. 49–63, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Biala, K. Pekala, A. Boguszewska-Czubara, A. Michalak, M. Kruk-Slomka, and B. Budzynska, “Behavioral and biochemical interaction between nicotine and chronic unpredictable mild stress in mice,” Molecular Neurobiology, vol. 54, no. 2, pp. 904–921, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Sinha, M. Ekka, U. Sharma, P. Raghunandan, R. M. Pandey, and N. R. Jagannathan, “Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy,” BMC Research Notes, vol. 7, no. 1, p. 41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. B. S. Hemanth Kumar, S. K. Mishra, P. Rana, S. Singh, and S. Khushu, “Neurodegenerative evidences during early onset of depression in CMS rats as detected by proton magnetic resonance spectroscopy at 7 T,” Behavioural Brain Research, vol. 232, no. 1, pp. 53–59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Zheng, Y. Zheng, D. Wang et al., “Analysis of neuron-astrocyte metabolic cooperation in the brain of db/db mice with cognitive decline using 13C NMR spectroscopy,” Journal of Cerebral Blood Flow & Metabolism, vol. 37, no. 1, pp. 332–343, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Garcia-Espinosa, M. L. Garcia-Martin, and S. Cerdan, “Role of glial metabolism in diabetic encephalopathy as detected by high resolution 13C NMR,” NMR in Biomedicine, vol. 16, no. 6-7, pp. 440–449, 2003. View at Publisher · View at Google Scholar
  32. G. Sanacora, D. L. Rothman, G. Mason, and J. H. Krystal, “Clinical studies implementing glutamate neurotransmission in mood disorders,” Annals of the New York Academy of Sciences, vol. 1003, no. 1, pp. 292–308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. A. D. Stan, C. V. Schirda, M. A. Bertocci et al., “Glutamate and GABA contributions to medial prefrontal cortical activity to emotion: implications for mood disorders,” Psychiatry Research, vol. 223, no. 3, pp. 253–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Krzyzanowska, B. Pomierny, M. Filip, and J. Pera, “Glutamate transporters in brain ischemia: to modulate or not?” Acta Pharmacologica Sinica, vol. 35, no. 4, pp. 444–462, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. F. C. Roth and A. Draguhn, “GABA metabolism and transport: effects on synaptic efficacy,” Neural Plasticity, vol. 2012, Article ID 805830, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Wu and D. Sun, “GABA receptors in brain development, function, and injury,” Metabolic Brain Disease, vol. 30, no. 2, pp. 367–379, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Antony, T. P. Kumar, K. P. Kuruvilla, N. George, and C. S. Paulose, “Decreased GABA receptor binding in the cerebral cortex of insulin induced hypoglycemic and streptozotocin induced diabetic rats,” Neurochemical Research, vol. 35, no. 10, pp. 1516–1521, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Gardoni, A. Kamal, C. Bellone et al., “Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats,” Journal of Neurochemistry, vol. 80, no. 3, pp. 438–447, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. C. P. Chih and E. L. Roberts Jr., “Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis,” Journal of Cerebral Blood Flow & Metabolism, vol. 23, no. 11, pp. 1263–1281, 2003. View at Publisher · View at Google Scholar
  40. A. Sartorius, P. Lugenbiel, M. M. Mahlstedt, G. Ende, P. Schloss, and B. Vollmayr, “Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain,” Journal of Neuroscience Methods, vol. 172, no. 2, pp. 215–219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. N. C. Patel, K. M. Cecil, S. M. Strakowski, C. M. Adler, and M. P. DelBello, “Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex,” Journal of Child and Adolescent Psychopharmacology, vol. 18, no. 6, pp. 623–627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. M. van der Graaf, S. W. Janssen, J. J. van Asten et al., “Metabolic profile of the hippocampus of Zucker diabetic fatty rats assessed by in vivo 1H magnetic resonance spectroscopy,” NMR in Biomedicine, vol. 17, no. 6, pp. 405–410, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Mao, J. Fang, H. Xie et al., “Correlation between neurochemical metabolism and memory function in adolescent patients with depression: a multi-voxel 1H magnetic resonance spectroscopy study,” Psychiatry and Clinical Neurosciences, vol. 70, no. 4, pp. 167–174, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Mangia, A. F. Kumar, A. A. Moheet et al., “Neurochemical profile of patients with type 1 diabetes measured by 1H-MRS at 4 T,” Journal of Cerebral Blood Flow & Metabolism, vol. 33, no. 5, pp. 754–759, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Fayed, J. Garcia-Campayo, R. Magallon et al., “Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate,” Arthritis Research & Therapy, vol. 12, no. 4, p. R134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. X. Zhang, H. Liu, J. Wu, X. Zhang, M. Liu, and Y. Wang, “Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats,” Neurochemistry International, vol. 54, no. 8, pp. 481–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Cordoba, F. Sanpedro, J. Alonso, and A. Rovira, “1H magnetic resonance in the study of hepatic encephalopathy in humans,” Metabolic Brain Disease, vol. 17, no. 4, pp. 415–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Makimattila, K. Malmberg-Ceder, A. M. Hakkinen et al., “Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury,” Journal of Cerebral Blood flow and Metabolism, vol. 24, no. 12, pp. 1393–1399, 2004. View at Publisher · View at Google Scholar
  49. H. Zhang, M. Huang, L. Gao, and H. Lei, “Region-specific cerebral metabolic alterations in streptozotocin-induced type 1 diabetic rats: an in vivo proton magnetic resonance spectroscopy study,” Journal of Cerebral Blood Flow and Metabolism, vol. 35, no. 11, pp. 1738–1745, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. C. X. Li, Y. Wang, H. Gao et al., “Cerebral metabolic changes in a depression-like rat model of chronic forced swimming studied by ex vivo high resolution 1H magnetic resonance spectroscopy,” Neurochemical Research, vol. 33, no. 11, pp. 2342–2349, 2008. View at Publisher · View at Google Scholar · View at Scopus